Category: COVID-19 20 May 2020
Cardiac Safety Conference
Date: May 20th, Wednesday
Location: online event
In celebration of the World Clinical Trials Day, the RRI and RPL are proud to host a Cardiac Safety Conference to discuss emerging drug development programmes. The event will discuss new insights into improved patient outcomes, efficiency and cost effectiveness of global drug development.
We are delighted to welcome expert speakers including:
- Professor John Camm, St George’s University of London
- Professor Atsushi Siguyama, Toho University
- Dr Jorg Taubel, RRI and RPL
- Dr Fabio Badilini, AMPS, New York
- Dr Krishna Prasad, MHRA, London
- Boaz Mendzelevski, Cardiac Safety Consultants
- Georg Ferber, Statistik Georg Ferber GmbH
About Richmond Research Institute
The Richmond Research Institute is an independent, academic research unit dedicated to understanding and improving the safety of pharmaceuticals. Our academic rigor to studying drug safety and drug interactions bridges the gap between industry and academia. In collaboration with St George’s University of London and other academic partners, we strive to overcome many of the challenges involved in medical and clinical research. With access to state-of-art facilities at Richmond Pharmacology – a London-based research unit – we are committed to improving clinical trial designs for more efficient and rapid conclusion.
About Richmond Pharmacology Ltd
For over 15 years, Richmond Pharmacology has delivered clinical excellence from design to delivery of early phase clinical trials, going from strength to strength in a fiercely competitive market place. We have experience that is held by our long serving management team and are reputed for our customer focus, flexible approach and strong project management. We have conducted over 300 Early Phase Studies.
Contact: Jack Wilmott, Head of Corporate Marketing, Richmond Pharmacology Ltd